AIIMS study finds catheter infections in hospital widespread across India

New Delhi: Bloodstream infections acquired during a hospital stay due to the use of a catheter are prevalent across ICUs in India and are often caused by microbes having a high level of antibiotic resistance, according to a study led by the All India Institute of Medical Sciences, New Delhi.

Antibiotic resistance — in which antibiotic drugs are rendered ineffective because disease-causing microbes have become immune to them — can extend one’s hospital stay and treatment costs, adding stress to a public healthcare system.

Estimates published in The Lancet Global Health journal show that on average, around nine bloodstream infection events occur every 1,000 days that a central line — a catheter inserted in a patient’s large vein instead of an intravenous line — was in place in the intensive care units (ICUs) of Indian hospitals.

‘Central line-associated bloodstream infections’, or CLABSI, are preventable infections — often acquired from a hospital environment — and significantly contribute to illness and death in low- and middle-income countries, including India.

The researchers said that tracking rates of bloodstream infections in ICUs can help countries develop preventive measures suited to a healthcare system.

However, setting up a surveillance that systematically tracks infections due to catheter use or other hospital-acquired infections calls for a significant amount of resources and is a challenge in low- and middle-income countries, including India, they said.

The team analysed data from 200 intensive care units received by the Indian Healthcare-Associated Infections (HAI) surveillance network from 54 hospitals across the country over a period of seven years.

“During the surveillance period from May 1, 2017, to April 30, 2024, 8,629 laboratory-confirmed CLABSI events, 3,054,124 patient-days and 977,052 central line-days were recorded. The overall pooled CLABSI rate was 8.83 per 1,000 central line-days,” the authors wrote.

Highest rates of bloodstream infections linked to central line catheter use were seen to occur during 2020-21, coinciding with the Covid-19 pandemic, which the researchers said may be due to overwhelmed ICUs, staff shortage and compromised infection prevention measures.

The study — first large-scale observational one, providing a standardised surveillance report of CLABSI in India — provides a valuable opportunity for a quality improvement-based approach for the reduction of CLABSI, the authors said.

Related Posts

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27 Piramal Pharma expects to sustain mid-teen revenue growth…

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bhubaneswar: Researchers from the Sensors and Spectroscopy Research Group, School of Electrical and Computer Sciences (SECS), Indian Institute of Technology (IIT) Bhubaneswar, led by Dr. Sayan Dey, have made significant…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses